Profile data is unavailable for this security.
About the company
Dominari Holdings Inc. is a holding company. The Company, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading and asset management. It operates through its wholly owned subsidiaries, including Dominari Financial Inc. (Dominari Financial) and Dominari Securities LLC (Dominari Securities). Dominari Securities offers and plans to offer a range of broker-dealer and registered investment adviser services. Its services include wealth management, investment banking, sales and trading, asset management and insurance products. Dominari Securities provides a comprehensive array of financial services to high-net-worth individuals and families, corporate executives, and public and private businesses. Dominari Securities also provides full-service brokerage, wealth planning and margin lending services. Dominari Securities’ investment banking division provides strategic advisory services and capital markets products to middle market businesses.
- Revenue in USD (TTM)9.51m
- Net income in USD-22.02m
- Incorporated1992
- Employees26.00
- LocationDominari Holdings Inc725 FIFTH AVENUE, 22ND FLOORNEW YORK 10022United StatesUSA
- Phone+1 (212) 393-4540
- Fax+1 (302) 674-5266
- Websitehttps://aikidopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mustang Bio Inc | 0.00 | -32.06m | 9.49m | 80.00 | -- | -- | -- | -- | -2.91 | -2.91 | 0.00 | -0.2384 | 0.00 | -- | -- | 0.00 | -170.53 | -70.02 | -727.24 | -79.98 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 33.44 | -- | -60.75 | -- |
| NKGen Biotech Inc | 0.00 | -88.25m | 9.69m | 63.00 | -- | -- | -- | -- | -3.74 | -3.74 | 0.00 | -2.71 | 0.00 | -- | -- | 0.00 | -480.25 | -- | -- | -- | -- | -- | -- | -- | -- | -0.4822 | -- | -- | -100.00 | -- | -210.06 | -- | -- | -- |
| Senti Biosciences Inc | 338.00k | -78.62m | 9.71m | 48.00 | -- | 0.2196 | -- | 28.72 | -17.52 | -12.65 | 0.0749 | 9.66 | 0.0029 | -- | 1.12 | 7,041.67 | -68.20 | -- | -74.50 | -- | -- | -- | -23,259.47 | -- | -- | -- | 0.0023 | -- | -40.25 | -- | -67.94 | -- | -- | -- |
| Vincerx Pharma Inc | 0.00 | -28.90m | 9.71m | 42.00 | -- | 0.6287 | -- | -- | -1.31 | -1.31 | 0.00 | 0.5206 | 0.00 | -- | -- | 0.00 | -101.76 | -- | -136.61 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 36.24 | -- | -- | -- |
| Viaderma Inc | 17.80m | 2.31m | 9.87m | 75.00 | 0.0005 | 0.00003 | 1.82 | 0.5545 | 16.84 | 16.84 | 129.62 | 255.59 | 0.4126 | 24.69 | 1.21 | 237,331.30 | 5.36 | -- | 6.53 | -- | 28.90 | -- | 12.99 | -- | 2.07 | 5.66 | 0.1718 | -- | -29.15 | -- | -40.70 | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -2.54m | 10.33m | 8.00 | -- | -- | -- | -- | -0.3796 | -0.3796 | 0.00 | -0.9226 | 0.00 | -- | -- | 0.00 | -9.96 | -- | -33.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -279.82 | -- | -- | -- |
| Yubo International Biotech Ltd | 454.29k | -1.42m | 10.40m | 18.00 | -- | -- | -- | 22.89 | -0.0118 | -0.0118 | 0.0038 | -0.0211 | 0.2462 | 0.5986 | 3.49 | 25,238.33 | -82.33 | -- | -- | -- | 80.30 | -- | -334.36 | -- | 0.1707 | -4,795.69 | -- | -- | 479.86 | -- | 0.8224 | -- | -- | -- |
| Kiora Pharmaceuticals Inc | 16.02m | 2.67m | 10.47m | 12.00 | -- | 0.3163 | 3.88 | 0.6536 | -7.76 | -7.76 | 6.61 | 11.14 | 0.5279 | -- | 7.16 | 1,335,000.00 | 10.54 | -70.52 | 11.20 | -81.86 | -- | -- | 19.98 | -2,040.61 | -- | -- | 0.00 | -- | -- | -- | 3.97 | -- | -- | -- |
| Dominari Holdings Inc | 9.51m | -22.02m | 10.49m | 26.00 | -- | 0.2463 | -- | 1.10 | -3.85 | -3.85 | 1.67 | 6.78 | 0.1629 | -- | 2.60 | 365,730.80 | -37.71 | -26.82 | -39.96 | -27.45 | -- | -- | -231.55 | -3,353.52 | -- | -5.05 | 0.00 | -- | -- | 135.75 | 12.72 | -- | 63.99 | -- |
| Ensysce Biosciences Inc | 1.44m | -11.28m | 10.89m | 7.00 | -- | 3.29 | -- | 7.57 | -2.98 | -2.98 | 0.2845 | 0.2218 | 0.3142 | -- | 8.67 | 205,418.60 | -246.46 | -17.68 | -376.98 | -19.42 | -- | -- | -784.43 | -715.78 | -- | -5.93 | 0.235 | -- | -11.61 | -- | 57.64 | -- | -- | -- |
| Conduit Pharmaceuticals Inc | 0.00 | -5.17m | 10.93m | 7.00 | -- | -- | -- | -- | -0.0667 | -0.0667 | 0.00 | -0.0738 | 0.00 | -- | -- | 0.00 | -312.39 | -- | -- | -- | -- | -- | -- | -- | -- | -21.32 | -- | -- | -- | -- | 89.05 | -- | -- | -- |
| Biora Therapeutics Inc | 860.00k | -86.81m | 11.02m | 58.00 | -- | -- | -- | 12.82 | -55.72 | -55.63 | 0.2398 | -24.85 | 0.0253 | -- | 1.05 | 14,827.59 | -255.56 | -122.84 | -- | -369.01 | -- | -- | -10,094.19 | -415.10 | -- | -- | -- | -- | -98.69 | -87.44 | -154.63 | -- | -53.68 | -- |
| BioRestorative Therapies Inc | 174.10k | -8.00m | 11.14m | 11.00 | -- | 1.03 | -- | 63.99 | -1.22 | -1.22 | 0.029 | 1.56 | 0.0118 | -- | 6.65 | 15,827.27 | -54.42 | -192.11 | -68.75 | -329.32 | 47.45 | -- | -4,597.79 | -19,116.15 | -- | -- | 0.00 | -- | 21.70 | 5.61 | 43.67 | -- | 67.77 | -- |
| Cingulate Inc | 0.00 | -19.10m | 11.15m | 13.00 | -- | 0.8786 | -- | -- | -141.60 | -141.60 | 0.00 | 3.95 | 0.00 | -- | -- | 0.00 | -368.85 | -- | -- | -- | -- | -- | -- | -- | -- | -47.38 | 0.0042 | -- | -- | -- | -33.14 | -- | -- | -- |
| Nascent Biotech Inc | 0.00 | -1.92m | 11.45m | -- | -- | -- | -- | -- | -0.012 | -0.012 | 0.00 | -0.003 | 0.00 | -- | -- | -- | -1,256.81 | -708.50 | -- | -- | -- | -- | -- | -589.83 | -- | -- | -- | -- | -- | -- | 25.47 | -- | -- | -- |
Data as of Nov 11 2024. Currency figures normalised to Dominari Holdings Inc's reporting currency: US Dollar USD
7.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 193.39k | 3.08% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 72.52k | 1.16% |
| Geode Capital Management LLCas of 30 Jun 2024 | 46.11k | 0.74% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 45.93k | 0.73% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 39.83k | 0.64% |
| Bridgeway Capital Management LLCas of 30 Jun 2024 | 20.50k | 0.33% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 19.99k | 0.32% |
| G1 Execution Services LLCas of 30 Jun 2024 | 16.54k | 0.26% |
| Tower Research Capital LLCas of 30 Jun 2024 | 5.67k | 0.09% |
| National Bank Financial, Inc.as of 30 Jun 2024 | 176.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
